COMP <GO>
MMED vs TFX // RSI-14 & 200D SMA MOMENTUM
MiniMed Group Inc. (NASDAQ) VS. Teleflex Incorporated (NYSE) • 15-METRIC TALLY: MMED 6
— TFX 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TFX
LAST: $19.25 (+0.21%) • MKT CAP: $5.42B
rsi-technicals
51.8
LAST: $141.39 (+1.73%) • MKT CAP: $5.99B
rsi-technicals
70.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMED VS. TFX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMED | TFX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.20% | 56.20% | -2.00 | TFX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | 1.80% | -5.70 | TFX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 40.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.75% | -18.00% | +10.25 | MMED | /fcf-yield <GO> |
| Operating Margin | -6.10% | 5.90% | -12.00 | TFX | /operating-margins <GO> |
| Net Profit Margin | -10.70% | -45.40% | +34.70 | MMED | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | 17.20% | -2.90 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.01% | -1.01 | TFX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.82 | 2.12 | +2.70 | MMED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | MMED | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 51.8 | 70.2 | -18.40 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.98 | +0.07 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | 27.0x | -3.00 | MMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.42B | $5.99B | -$575.0M | TFX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMED REV | TFX REV | MMED GROSS % | TFX GROSS % | MMED FCF | TFX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.10B | $1.99B | 54.2% | 56.2% | -$420.0M | — |
| FY 2024 | $2.71B | $1.70B | 56.3% | 61.0% | -$53.0M | — |
| FY 2023 | $2.47B | $1.71B | — | — | -$70.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMED // BETA 1.05
TFX // BETA 0.98